Discontinuation report COUMADIN TAB 1MG
Report ID | 19592 |
Drug Identification Number | 01918311 |
Brand name | COUMADIN TAB 1MG |
Common or Proper name | Warfarin |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | WARFARIN SODIUM |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BTL x 250 |
ATC code | B01AA |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-01-31 |
Actual discontinuation date | 2018-01-31 |
Remaining supply date | 2018-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Only the bottles of 250`s will be discontinued. |
Company comments | The bottles of 100`s will continue to be available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-08-16 | English | Compare |
v2 | 2017-08-16 | French | Compare |
v3 | 2018-03-16 | English | Compare |
v4 | 2018-03-16 | French | Compare |
Showing 1 to 4 of 4